P109 | A MULTICENTER RETROSPECTIVE ANALYSIS OF ZANUBRUTINIB THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA ("PARTENOPE PROJECT"): REPORT FROM THE CAMPANIA NETWORK ON CHRONIC LYMPHOCYTIC LEUKEMIA

Zanubrutinib, a selective second-generation covalent Bruton tyrosine kinase inhibitor approved in various B-cell malignancies, has showed its activity in B-cell chronic lymphocytic leukemia (CLL). Here we report the preliminary data of a multicenter experience on therapy with zanubrutinib in de nov...

Descrizione completa

Dettagli Bibliografici

Autori principali:	G. D'arena, M. Lucignano, A. Fresa, G.R. Nunziata, F. Graziani, V. Amico, M. Troiano, R. Fontana, C. Giordano, G. Svanera, V. Sammartano
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Ferrata Storti Foundation 2025-09-01
Serie:	Haematologica
Accesso online:	https://haematologica.org/article/view/12406
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!